Terms: = Ovarian cancer AND IRF4, LSIRF, 3662, ENSG00000137265, Q15306 AND Diagnosis
3 results:
1. External Validation of the ovarian-Adnexal Reporting and Data System (O-RADS) Lexicon and the International ovarian Tumor Analysis 2-Step Strategy to Stratify ovarian Tumors Into O-RADS Risk Groups.
Timmerman S; Valentin L; Ceusters J; Testa AC; Landolfo C; Sladkevicius P; Van Holsbeke C; Domali E; Fruscio R; Epstein E; Franchi D; Kudla MJ; Chiappa V; Alcazar JL; Leone FPG; Buonomo F; Coccia ME; Guerriero S; Deo N; Jokubkiene L; Kaijser J; Scambia G; Andreotti R; Timmerman D; Bourne T; Van Calster B; Froyman W
JAMA Oncol; 2023 Feb; 9(2):225-233. PubMed ID: 36520422
[TBL] [Abstract] [Full Text] [Related]
2. Imaging in gynecological disease (9): clinical and ultrasound characteristics of tubal cancer.
Ludovisi M; De Blasis I; Virgilio B; Fischerova D; Franchi D; Pascual MA; Savelli L; Epstein E; Van Holsbeke C; Guerriero S; Czekierdowski A; Zannoni G; Scambia G; Jurkovic D; Rossi A; Timmerman D; Valentin L; Testa AC
Ultrasound Obstet Gynecol; 2014 Mar; 43(3):328-35. PubMed ID: 23893713
[TBL] [Abstract] [Full Text] [Related]
3. Expression of the B-cell proliferation marker MUM1 by melanocytic lesions and comparison with S100, gp100 (HMB45), and MelanA.
Sundram U; Harvell JD; Rouse RV; Natkunam Y
Mod Pathol; 2003 Aug; 16(8):802-10. PubMed ID: 12920225
[TBL] [Abstract] [Full Text] [Related]
